Ueda Mayu, Matsuda Katsuya, Kurohama Hirokazu, Mussazhanova Zhanna, Sailaubekova Yerkezhan, Kondo Hisayoshi, Shimizu Tomoki, Takada Nami, Matsuoka Yuki, Otsubo Chieko, Sato Shinya, Yamashita Hiroyuki, Kawakami Atsushi, Nakashima Masahiro
Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8523, Japan.
Department of Endocrinology and Metabolism, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki 852-8501, Japan.
Cancers (Basel). 2022 Jul 22;14(15):3577. doi: 10.3390/cancers14153577.
Thyroid follicular-patterned tumors (TFTs) showing nodule-in-nodule (NN) appearance with poorly differentiated component (PDc) but neither invasion nor metastasis are diagnosed as benign nodules. Although PDc exhibits histologically aggressive features relative to the outer nodule (Out-N), its pathological significance remains unclear. TP53 binding protein-1 (53BP1) is a DNA damage response (DDR) molecule that rapidly localizes at DNA double-strand breaks. Using dual-color immunofluorescence with Ki-67, the profile of 53BP1 expression is shown to be significantly altered during diverse tumorigenesis. In this study, we aimed to elucidate the malignant potential of PDc at the molecular level. We analyzed the profile of 53BP1 expression and and -promoter (-p) mutations in 16 cases of TFTs showing NN with PDc compared to 30 adenomatous goiters, 31 follicular adenomas, 15 minimally invasive follicular carcinomas (FCs), and 11 widely invasive FC cases. Our results revealed that the expression level of abnormal type 53BP1 and incidence of and -p mutations in PDc were comparable to FCs, suggesting a malignant potential. Because co-expression of 53BP1 and Ki-67 can be an indicator of altered DDR, the development of PDc in NN may be associated with DDR impairments after harboring and -p mutations.
呈现结节内结节(NN)外观且伴有低分化成分(PDc)但无侵袭或转移的甲状腺滤泡型肿瘤(TFTs)被诊断为良性结节。尽管相对于外部结节(Out-N),PDc在组织学上表现出侵袭性特征,但其病理意义仍不清楚。TP53结合蛋白1(53BP1)是一种DNA损伤反应(DDR)分子,可迅速定位于DNA双链断裂处。通过与Ki-67进行双色免疫荧光检测,发现53BP1的表达谱在不同的肿瘤发生过程中发生了显著改变。在本研究中,我们旨在从分子水平阐明PDc的恶性潜能。我们分析了16例伴有PDc的NN型TFTs中53BP1的表达谱以及 和 -启动子(-p)突变情况,并与30例腺瘤性甲状腺肿、31例滤泡性腺瘤、15例微侵袭性滤泡癌(FCs)和11例广泛侵袭性FC病例进行了比较。我们的结果显示,PDc中异常型53BP1的表达水平以及 和 -p突变的发生率与FCs相当,提示其具有恶性潜能。由于53BP1和Ki-67的共表达可能是DDR改变的一个指标,NN中PDc的发生可能与携带 和 -p突变后的DDR损伤有关。